HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Denies Petition Recommending CoQ10/Statin Use, Draws Lawsuit

This article was originally published in The Tan Sheet

Executive Summary

Supplement industry stakeholders claim FDA is putting statin patients at risk by not requiring labeling that would recommend users of the cholesterol-lowering drugs take supplemental CoQ10

You may also be interested in...

CoQ10 Adjunctive Use With Rx Statins Encouraged In Citizen Petition

Supplementing statin drug use with coenzyme Q10 could help between 125,000 and 575,000 people avoid statin-induced liver dysfunction, cardiomyopathy or congestive heart failure, Julian Whitaker, MD, asserts in a May 29 citizen petition submitted to FDA

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts